According to a new report by Polaris Market Research, the global Human Microbiome Therapeutics market was valued at USD 1.01 billion in 2024 and is projected to reach USD 7.89 billion by 2034, expanding at a CAGR of 22.80% over the forecast period. Growth is underpinned by the rising prevalence of chronic and gastrointestinal diseases, expanding interest in personalized medicine, and...